EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome

I Selten iD, J Blok, T Boerma, A A A M J Djelantik, M Houben, F Wijnen, J Zinkstok, J A S Vorstman, A M Fiksinski

Journal of Intellectual Disability Research · 2025-02 · 69 (2) · 113-126

DOI: 10.1111/jir.13196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Intellectual Disability Research, online erschienen am 22.10.2024. Verfasst von I Selten und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Language Sciences, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: DiGeorge Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Organization for Scientific Research, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The 22q11.2 deletion syndrome (22q11DS) is associated with a variety of neuropsychiatric outcomes that vary across deletion carriers. We adopted a dimensional approach to provide a comprehensive overview of neuropsychiatric symptom expression in adolescents with 22q11DS and further our understanding of the observed phenotypical heterogeneity.

Methods

Participants were 208 adolescents with 22q11DS between 10 and 19 years old. Semi‐structured clinical interviews and IQ tests were used to quantify symptom expression on multiple symptom dimensions, some reflecting DSM‐IV diagnostic domains. We investigated symptom expression in those with and without a formal DSM‐IV classification and examined between and within symptom dimensions. We used correlation analyses to explore associations between different symptom dimensions.

Results

We demonstrated inter‐individual differences in symptom expression, both between and within neuropsychiatric symptom dimensions. On most symptom dimensions, more than 50% of adolescents expressed at least one clinically relevant symptom. In addition, a significant proportion of youth without a formal DSM‐IV diagnosis reported clinically relevant symptoms (e.g. >85% of those without an ADHD diagnosis reported ADHD symptoms). The exploratory correlation analysis indicated mostly positive correlations between symptom dimensions.

Conclusions

The finding that most adolescents with 22q11DS express neuropsychiatric symptoms, even in the absence of a DSM‐IV classification, has substantial ramifications for guiding adequate support. Findings may spur further research into the dimensional structure of neuropsychiatric symptoms in 22q11DS and aid in uncovering mechanisms that contribute to symptom expression. Ultimately, this provides leads to improve clinical care for 22q11DS and to understand phenotypical variation in other high‐risk genetic variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiGeorge SyndromeAdolescentChildFemaleHumansMaleYoung Adult

Stichwörter der Autor:innen

22q11DSdimensionsneurodevelopmentpsychiatrysymptom expression

Autor:innen und Institutionen

  • Institute for Language Sciences, Utrecht University, Utrecht, The Netherlands.
  • Department of Psychiatry and Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Pediatrics, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
  • Dutch Autism & ADHD Research Center, Department of psychology, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Child and Adolescent Psychiatry, Karakter, Nijmegen, The Netherlands.

ORCID-Profile: I Selten

Förderung

  • Dutch Organization for Scientific Research
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Selten, I., Blok, J., Boerma, T., Djelantik, A. A. A. M. J., Houben, M., Wijnen, F., Zinkstok, J., Vorstman, J. A. S., & Fiksinski, A. M. (2025). A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome. Journal of Intellectual Disability Research, 69(2), 113-126. https://doi.org/10.1111/jir.13196

Vancouver

Selten I, Blok J, Boerma T, Djelantik AAAMJ, Houben M, Wijnen F, et al. A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome. Journal of Intellectual Disability Research. 2025;69(2):113-126. doi:10.1111/jir.13196

BibTeX
@article{Selten2025,
  author = {Selten, I and Blok, J and Boerma, T and Djelantik, A A A M J and Houben, M and Wijnen, F and Zinkstok, J and Vorstman, J A S and Fiksinski, A M},
  title = {A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome},
  journal = {Journal of Intellectual Disability Research},
  year = {2025},
  volume = {69},
  number = {2},
  pages = {113--126},
  doi = {10.1111/jir.13196}
}
Kostenlos starten →